The ACTN4 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma cell line. This loss-of-function model targets alpha-actinin-4 (ACTN4), an actin-crosslinking protein. The polyclonal format provides a heterogeneous pool of edited cells, avoiding clonal bias and offering a robust system for gene function studies. CRISPR/Cas9-mediated disruption of ACTN4 generates a stable knockout model for investigating cytoskeletal dynamics, cell adhesion, and motility pathways in an epithelial background.
The A-549 host cell line is a widely used model of human lung adenocarcinoma, established from a 58-year-old male. These epithelial cells exhibit type II pneumocyte characteristics and harbor an oncogenic KRAS G12S mutation, which activates MAPK and PI3K signaling. A-549 cells are extensively employed to study tumorigenesis, drug resistance, and metastatic progression. Their genetic profile and epithelial morphology make them particularly well-suited for analyzing how oncogenic mutations coordinate with actin cytoskeletal remodeling to drive invasive behavior.
Alpha-actinin-4 crosslinks filamentous actin (F-actin) into bundles and links the cytoskeleton to focal adhesions by interacting with vinculin and integrin beta1. Its activity is regulated by TGF-beta, EGF, and HGF, which modulate expression via transcription factors Snail and Slug. At focal adhesions, ACTN4 assembles signaling complexes containing FAK, AKT1, and Rho-family GTPases Rac1, Cdc42, and RhoA, connecting mechanical inputs to actin reorganization. ACTN4 also binds beta-catenin, MAGI-1, and TESK1, contributing to adhesive and transcriptional functions. Downstream, ACTN4-driven actin polymerization promotes lamellipodia formation, MRTF-A nuclear translocation, and SRF-mediated transcription of genes driving cell migration and matrix remodeling.
In the KRAS-mutant A-549 context, ACTN4 knockout is instrumental for studying lung adenocarcinoma invasion and metastasis. Loss of ACTN4 impairs focal adhesion integrity and actin stress fiber organization, reducing cell migration and invasion. This model enables dissection of how growth factor and integrin signals integrate with actin dynamics and allows interrogation of crosstalk between TGF-beta, Wnt, and PI3K-Akt pathways often dysregulated in lung cancer. Eliminating ACTN4 function permits assessment of this scaffold protein in tumor cell plasticity, epithelial-mesenchymal transition, and chemoresistance.
Key applications include wound healing and transwell migration/invasion assays to quantify motility defects, immunofluorescence for actin filaments and focal adhesion markers like paxillin, and co-immunoprecipitation of ACTN4 partners. The cells are also suitable for phospho-signaling arrays to map altered kinase networks and RNA-seq transcriptomics to identify gene expression changes upon ACTN4 loss. These methods advance functional genomics of lung adenocarcinoma and support drug screens targeting the cytoskeleton or adhesion signaling. For more information, contact Ascent Research.
